Literature DB >> 25623066

Functional coupling of ATP-binding cassette transporter Abcb6 to cytochrome P450 expression and activity in liver.

Hemantkumar Chavan1, Feng Li1, Robert Tessman1, Kristen Mickey1, Kenneth Dorko2, Timothy Schmitt3, Sean Kumer3, Sumedha Gunewardena4, Nilesh Gaikwad5, Partha Krishnamurthy6.   

Abstract

Although endogenous mechanisms that negatively regulate cytochrome P450 (P450) monooxygenases in response to physiological and pathophysiological signals are not well understood, they are thought to result from alterations in the level of endogenous metabolites, involved in maintaining homeostasis. Here we show that homeostatic changes in hepatic metabolite profile in Abcb6 (mitochondrial ATP-binding cassette transporter B6) deficiency results in suppression of a specific subset of hepatic P450 activity. Abcb6 null mice are more susceptible to pentobarbital-induced sleep and zoxazolamine-induced paralysis, secondary to decreased expression and activity of Cyp3a11 and Cyp2b10. The knock-out mice also show decrease in both basal and xeno-inducible expression and activity of a subset of hepatic P450s that appear to be related to changes in hepatic metabolite profile. These data, together with the observation that liver extracts from Abcb6-deficient mice suppress P450 expression in human primary hepatocytes, suggest that this mouse model may provide an opportunity to understand the physiological signals and the mechanisms involved in negative regulation of P450s.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ABC Transporter; Cytochrome P450; Gene Regulation; Membrane Transport; Metabolic Regulation

Mesh:

Substances:

Year:  2015        PMID: 25623066      PMCID: PMC4367286          DOI: 10.1074/jbc.M114.605386

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism.

Authors:  P Wei; J Zhang; M Egan-Hafley; S Liang; D D Moore
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

Review 2.  The human hepatic cytochromes P450 involved in drug metabolism.

Authors:  S A Wrighton; J C Stevens
Journal:  Crit Rev Toxicol       Date:  1992       Impact factor: 5.635

Review 3.  Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation.

Authors:  F J Gonzalez; D W Nebert
Journal:  Trends Genet       Date:  1990-06       Impact factor: 11.639

4.  Heme may not be a positive regulator of cytochrome-P450 gene expression.

Authors:  G Srivastava; M J Bawden; A J Hansen; B K May
Journal:  Eur J Biochem       Date:  1989-01-02

Review 5.  P450 genes: structure, evolution, and regulation.

Authors:  D W Nebert; F J Gonzalez
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

Review 6.  Cytochrome P450: evolution and functional diversity.

Authors:  D W Nebert; R A McKinnon
Journal:  Prog Liver Dis       Date:  1994

Review 7.  Constitutive expression of hepatic cytochrome P450 genes.

Authors:  F J Gonzalez; Y H Lee
Journal:  FASEB J       Date:  1996-08       Impact factor: 5.191

8.  Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin.

Authors:  Po-Yung Cheng; Molin Wang; Edward T Morgan
Journal:  J Pharmacol Exp Ther       Date:  2003-10-13       Impact factor: 4.030

Review 9.  Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.

Authors:  David R Nelson; Darryl C Zeldin; Susan M G Hoffman; Lois J Maltais; Hester M Wain; Daniel W Nebert
Journal:  Pharmacogenetics       Date:  2004-01

10.  Role of heme in cytochrome P450 transcription and function in mice treated with lead acetate.

Authors:  R Jover; R L Lindberg; U A Meyer
Journal:  Mol Pharmacol       Date:  1996-09       Impact factor: 4.436

View more
  4 in total

1.  Nicotinamide Phosphoribosyltransferase Deficiency Potentiates the Antiproliferative Activity of Methotrexate through Enhanced Depletion of Intracellular ATP.

Authors:  Rakesh K Singh; Leon van Haandel; Daniel P Heruth; Shui Q Ye; J Steven Leeder; Mara L Becker; Ryan S Funk
Journal:  J Pharmacol Exp Ther       Date:  2018-02-02       Impact factor: 4.030

Review 2.  Dysfunctional mitochondrial bioenergetics and the pathogenesis of hepatic disorders.

Authors:  Christopher Auger; Azhar Alhasawi; Manuraj Contavadoo; Vasu D Appanna
Journal:  Front Cell Dev Biol       Date:  2015-06-25

3.  Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.

Authors:  Qifan Zhang; Shibo Sun; Chen Zhu; Yujian Zheng; Qing Cai; Xiaolu Liang; Haorong Xie; Jie Zhou
Journal:  Mol Med Rep       Date:  2019-02-04       Impact factor: 2.952

4.  Altered Function and Expression of ABC Transporters at the Blood-Brain Barrier and Increased Brain Distribution of Phenobarbital in Acute Liver Failure Mice.

Authors:  Li Liu; Mingxing Miao; Yang Chen; Zhongjian Wang; Binbin Sun; Xiaodong Liu
Journal:  Front Pharmacol       Date:  2018-03-06       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.